The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor

被引:210
|
作者
Ambartsumian, N [1 ]
Klingelhöfer, J
Grigorian, M
Christensen, C
Kriajevska, M
Tulchinsky, E
Georgiev, G
Berezin, V
Bock, E
Rygaard, J
Cao, RH
Cao, YH
Lukanidin, E
机构
[1] Danish Canc Soc, Dept Mol Canc Biol, DK-2100 Copenhagen O, Denmark
[2] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden
[3] Univ Copenhagen, Panum Inst, Prot Lab, DK-2200 Copenhagen N, Denmark
[4] Kommune Hosp Copenhagen, Bartholin Inst, DK-1399 Copenhagen K, Denmark
[5] Inst Gene Biol, Moscow, Russia
关键词
angiogenesis; S100A4; stimulation of motility;
D O I
10.1038/sj.onc.1204636
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The involvement of Mts1(S100A4), a small Call-binding protein in tumor progression and metastasis had been demonstrated. However, the mechanism by which mts1(S100A4) promoted metastasis had not been identified. Here we demonstrated that Mts1(S100A4) had significant stimulatory effect on the angiogenesis. We detected high incidence of hemangiomas - benign tumors of vascular origin in aged transgenic mice ubiquitously expressing the mts1(S100A4) gene. Furthermore, the serum level of the Mts1(Sl00A4) protein increased with ageing. Tumors developed in Mts1-transgenic mice revealed an enhanced vascular density. We showed that an oligomeric, but not a dimeric form of the Mts1(S100A4) protein was capable of enhancing the endothelial cell motility in vitro and stimulate the corneal neovascularization in vivo. An oligomeric fraction of the protein was detected in the conditioned media as well as in human serum. The data obtained allowed us to conclude that mts1(S100A4) might induce tumor progression via stimulation of angiogenesis.
引用
收藏
页码:4685 / 4695
页数:11
相关论文
共 50 条
  • [21] Absence of S100A4 (mts1) gene mutations in various canine and feline tumours.: Detection of a polymorphism in feline S100A4 (mts1)
    Mayr, B
    Brem, G
    Reifinger, M
    JOURNAL OF VETERINARY MEDICINE SERIES A-PHYSIOLOGY PATHOLOGY CLINICAL MEDICINE, 2000, 47 (02): : 123 - 128
  • [22] Metastasis-associated Mts1 (S100A4) protein is selectively expressed in white matter astrocytes and is up-regulated after peripheral nerve or dorsal root injury
    Kozlova, EN
    Lukanidin, E
    GLIA, 1999, 27 (03) : 249 - 258
  • [23] Metastasis-Inducing Mts1/S100A4 Protein Binds to Tumor Suppressor p53 Protein
    M. Grigorian
    E. Lukanidin
    Russian Journal of Genetics, 2003, 39 : 748 - 755
  • [24] Metastasis-inducing Mts1/S100A4 protein binds to tumor suppressor p53 protein
    Grigorian, M
    Lukanidin, E
    RUSSIAN JOURNAL OF GENETICS, 2003, 39 (07) : 748 - 755
  • [25] Transcription factor Oct-1 stimulates the release of Mts1/S100A4 protein by the cancer cells
    T. N. Portseva
    A. V. Brechalov
    E. A. Dukhanina
    A. G. Stepchenko
    E. V. Pankratova
    S. G. Georgieva
    Doklady Biochemistry and Biophysics, 2016, 467 : 121 - 123
  • [26] Transcription factor Oct-1 stimulates the release of Mts1/S100A4 protein by the cancer cells
    Portseva, T. N.
    Brechalov, A. V.
    Dukhanina, E. A.
    Stepchenko, A. G.
    Pankratova, E. V.
    Georgieva, S. G.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2016, 467 (01) : 121 - 123
  • [27] The link between metastasis-associated protein S100A4 and rheumatoid arthritis
    Senolt, L.
    JOINT BONE SPINE, 2008, 75 (02) : 242 - 243
  • [28] Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene
    Grum-Schwensen, B
    Klingelhofer, J
    Berg, CH
    El-Naaman, C
    Grigorian, M
    Lukanidin, E
    Ambartsumian, N
    CANCER RESEARCH, 2005, 65 (09) : 3772 - 3780
  • [29] METASTASIS-PROMOTING PROTEIN S100A4 (MTS1) UPREGULATES PRODUCTION OF PROINFLAMMATORY CYTOKINES VIA TLR-4
    Senolt, L.
    Cerezo, L.
    Vencovsky, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69
  • [30] Metastasis-associated protein S100A4 - A potential prognostic marker for colorectal cancer
    Hemandas, AK
    Salto-Tellez, M
    Maricar, SH
    Leong, AFPK
    Leow, CK
    JOURNAL OF SURGICAL ONCOLOGY, 2006, 93 (06) : 498 - 503